Estrogen receptors inhibit Smad3 transcriptional activity through Ap-1 transcription factors

Molecular and Cellular Biochemistry

Volumn 306, Issue 1-2, 2007, Pages 33-42

  Cherlet, Tracy ^a   Murphy, Leigh C ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Breast cancer; C jun; Cross talk; Estrogen receptors; Smad 3; Transforming growth factor

Indexed keywords

ANTIESTROGEN; ESTRADIOL; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; PROTEIN C JUN; SMAD3 PROTEIN; TRANSCRIPTION FACTOR AP 1; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICLE; AUTOCRINE EFFECT; BREAST CANCER; BREAST CARCINOGENESIS; CANCER GROWTH; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; METASTASIS; MOLECULAR INTERACTION; NONHUMAN; PARACRINE SIGNALING; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ANIMALS; BLOTTING, WESTERN; BREAST NEOPLASMS; CERCOPITHECUS AETHIOPS; COS CELLS; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GENE EXPRESSION REGULATION; HUMANS; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; RESPONSE ELEMENTS; SMAD3 PROTEIN; TRANS-ACTIVATORS; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 35548972489     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-007-9551-1     Document Type: Article

References (51)

1. Murphy LC, Watson P (2002) Steroid receptors in human breast tumorigenesis and breast cancer progression. Biomed Pharmacother 56:65-77
2. Woodward TL, Xie JW, Haslam SZ (1998) The role of mammary stroma in modulating the proliferative response to ovarian hormones in the normal mammary gland. J Mammary Gland Biol Neoplasia 3:117-131
3. Clarke RB, Howell A, Potten CS, Anderson E (1997) Dissociation between steroid receptor expression and cell proliferation in the human breast. Cancer Res 57:4987-4991
4. Murphy LC, Leygue E, Niu Y, Snell L, Ho SM, Watson PH (2002) Relationship of coregulator and oestrogen receptor isoform expression to de novo tamoxifen resistance in human breast cancer. Br J Cancer 87:1411-1416
5. Murphy LC, Simon SL, Parkes A, Leygue E, Dotzlaw H, Snell L, Troup S, Adeyinka A, Watson PH (2000) Altered expression of estrogen receptor coregulators during human breast tumorigenesis. Cancer Res 60:6266-6271
6. Reiss M, Barcellos-Hoff MH (1997) Transforming growth factor-beta in breast cancer: A working hypothesis. Breast Cancer Res Treat 45:81-95
7. Tong GM, Rajah TT, Zang XP, Pento JT (2002) The effect of antiestrogens on TGF-beta-mediated chemotaxis of human breast cancer cells. Anticancer Res 22:103-106
8. Koli KM, Arteaga CL (1996) Complex role of tumor cell transforming growth factor (TGF)-beta s on breast carcinoma progression. J Mammary Gland Biol Neoplasia 1:373-380
9. Xie W, Mertens JC, Reiss DJ, Rimm DL, Camp RL, Haffty BG, Reiss M (2002) Alterations of Smad signaling in human breast carcinoma are associated with poor outcome: A tissue microarray study. Cancer Res 62:497-505
10. Gorsch SM, Memoli VA, Stukel TA, Gold LI, Arrick BA (1992) Immunohistochemical staining for transforming growth factor beta 1 associates with disease progression in human breast cancer. Cancer Res 52:6949-6952
11. Walker RA, Dearing SJ (1992) Transforming growth factor beta 1 in ductal carcinoma in situ and invasive carcinomas of the breast. Eur J Cancer 28:641-644
12. Zugmaier G, Lippman ME (1990) Effects of TGF beta on normal and malignant mammary epithelium. Ann N Y Acad Sci 593:272-275
13. Benson JR, Baum M, Colletta AA (1996) Role of TGF beta in the anti-estrogen response/resistance of human breast cancer. J Mammary Gland Biol Neoplasia 1:381-389
14. Chen H, Tritton TR, Kenny N, Absher M, Chiu JF (1996) Tamoxifen induces TGF-beta 1 activity and apoptosis of human MCF-7 breast cancer cells in vitro. J Cell Biochem 61:9-17
15. Thompson AM, Kerr DJ, Steel CM (1991) Transforming growth factor beta 1 is implicated in the failure of tamoxifen therapy in human breast cancer. Br J Cancer 63:609-614
16. Matsuda T, Yamamoto T, Muraguchi A, Saatcioglu F (2001) Cross-talk between transforming growth factor-beta and estrogen receptor signaling through Smad3. J Biol Chem 276:42908-42914
17. Yamamoto T, Saatcioglu F, Matsuda T (2002) Cross-talk between bone morphogenic proteins and estrogen receptor signaling. Endocrinology 143:2635-2642
18. Yanagi Y, Suzawa M, Kawabata M, Miyazono K, Yanagisawa J, Kato S (1999) Positive and negative modulation of vitamin D receptor function by transforming growth factor-beta signaling through smad proteins. J Biol Chem 274:12971-12974
19. Yanagisawa J, Yanagi Y, Masuhiro Y, Suzawa M, Watanabe M, Kashiwagi K, Toriyabe T, Kawabata M, Miyazono K, Kato S (1999) Convergence of transforming growth factor-beta and vitamin D signaling pathways on SMAD transcriptional coactivators. Science 283:1317-1321
20. Song CZ, Tian X, Gelehrter TD (1999) Glucocorticoid receptor inhibits transforming growth factor-beta signaling by directly targeting the transcriptional activation function of Smad3. Proc Natl Acad Sci U S A 96:11776-11781
21. Hayes SA, Zarnegar M, Sharma M, Yang F, Peehl DM, ten Dijke P, Sun Z (2001) SMAD3 represses androgen receptor-mediated transcription. Cancer Res 61:2112-2118
22. Kang HY, Lin HK, Hu YC, Yeh S, Huang KE, Chang C (2001) From transforming growth factor-beta signaling to androgen action: identification of Smad3 as an androgen receptor coregulator in prostate cancer cells. Proc Natl Acad Sci U S A 98:3018-3023
23. Zheng L, Annab L, Afshari C, Lee W, Boyer T (2001) BRCA1 mediates ligand-independent transcriptional repression of the estrogen receptor. Proc Natl Acad Sci U S A 98:9587-9592
24. Peng B, Lu B, Leygue E, Murphy L (2003) Putative functional characteristics of human estrogen receptor-beta isoforms. J Mol Endocrinol 30:13-29
25. Peng B, Lu B, Leygue E, Murphy LC (2003) Putative functional characteristics of human estrogen receptor-beta isoforms. J Mol Endocrinol 30:13-29
26. Jordan M, Wurm F (2004) Transfection of adherent and suspended cells by calcium phosphate. Methods 33:136-143
27. Chipuk JE, Cornelius SC, Pultz NJ, Jorgensen JS, Bonham MJ, Kim SJ, Danielpour D (2002) The androgen receptor represses transforming growth factor-beta signaling through interaction with Smad3. J Biol Chem 277:1240-1248
28. Cowley S, Hoare S, Mosselman S, Parker M (1997) Estrogen receptors alpha and beta form heterodimers on DNA. J Biol Chem 272:19858-19862
29. Verrecchia F, Vindevoghel L, Lechleider RJ, Uitto J, Roberts AB, Mauviel A (2001) Smad3/AP-1 interactions control transcriptional responses to TGF-beta in a promoter-specific manner. Oncogene 20:3332-3340
30. Liberati NT, Datto MB, Frederick JP, Shen X, Wong C, Rougier-Chapman EM, Wang XF (1999). Smads bind directly to the Jun family of AP-1 transcription factors. Proc Natl Acad Sci U S A 96:4844-4849
31. Teyssier C, Belguise K, Galtier F, Chalbos D (2001) Characterization of the physical interaction between estrogen receptor alpha and JUN proteins. J Biol Chem 276:36361-36369
32. Jakacka M, Ito M, Weiss J, Chien PY, Gehm BD, Jameson JL (2001) Estrogen receptor binding to DNA is not required for its activity through the nonclassical AP1 pathway. J Biol Chem 276:13615-13621
33. Webb P, Lopez GN, Uht RM, Kushner PJ (1995) Tamoxifen activation of the estrogen receptor/AP-1 pathway: Potential origin for the cell-specific estrogen-like effects of antiestrogens. Mol Endocrinol 9:443-456
34. Ogawa S, Inoue S, Watanabe T, Orimo A, Hosoi T, Ouchi Y, Muramatsu M (1998) Molecular cloning and characterization of human estrogen receptor bcx: Potential inhibitor of estrogen action in human. Nucleic Acids Res 26:3505-3512
35. Leung Y, Mak P, Hassan S, Ho S (2006) Estrogen receptor (ER)-beta isoforms: A key to understanding ER-beta signaling. Proc Natl Acad Sci U S A. 103:13162-13167
36. Leygue E, Dotzlaw H, Watson P, Murphy L (1999) Expression of estrogen receptor beta1, beta2, and beta5 messenger RNAs in human breast tissue. Cancer Res 59:1175-1179
37. Saunders P, Millar M, Macpherson S, Irvine D, Groome N, Evans L, Sharpe R, Scobie G (2002) ERbeta1 and the ERbeta2 splice variant (ERbetacx/ beta2) are expressed in distinct cell populations in the adult human testis. J Clin Endocrinol Metab 87:2706-2715
38. Skliris G, Leygue E, Curtis-Snell L, Watson P, Murphy L (2006) Expression of oestrogen receptor-beta in oestrogen receptor-alpha negative human breast tumours. Br J Cancer 95:616-626
39. Saji S, Omoto Y, Shimizu C, Warner M, Hayashi Y, Horiguchi S, Watanabe T, Hayashi S, Gustafsson J (2002) Expression of estrogen receptor (ER) (beta)cx protein in ER(alpha)-positive breast cancer: Specific correlation with progesterone receptor. Cancer Res 62:4849-4853
40. Malek D, Gust R, Kleuser B (2006) 17-Beta-estradiol inhibits transforming-growth-factor-beta-induced MCF-7 cell migration by Smad3-repression. Eur J Pharmacol 534:39-47
41. Yamamura Y, Hua X, Bergelson S, Lodish HF (2000) Critical role of Smads and AP-1 complex in transforming growth factor-beta -dependent apoptosis. J Biol Chem 275:36295-36302
42. Yingling JM, Datto MB, Wong C, Frederick JP, Liberati NT, Wang XF (1997) Tumor suppressor Smad4 is a transforming growth factor beta-inducible DNA binding protein. Mol Cell Biol 17:7019-7028
43. Cheng CK, Chow BK, Leung PC (2003) An activator protein 1-like motif mediates 17beta-estradiol repression of gonadotropin-releasing hormone receptor promoter via an estrogen receptor alpha-dependent mechanism in ovarian and breast cancer cells. Mol Endocrinol 17:2613-2629
44. Qi X, Borowicz S, Pramanik R, Schultz RM, Han J, Chen G (2004) Estrogen receptor inhibits c-Jun-dependent stress-induced cell death by binding and modifying c-Jun activity in human breast cancer cells. J Biol Chem 279:6769-6777
45. Teyssier C, Belguise K, Galtier F, Chalbos D (2001) Characterization of the physical interaction between estrogen receptor alpha and JUN proteins. J Biol Chem 276:36361-36369
46. Dennler S, Pendaries V, Tacheau C, Costas M, Mauviel A, Verrecchia F (2005) The steroid receptor co-activator-1 (SRC-1) potentiates TGF-beta/ Smad signaling: Role of p300/CBP. Oncogene 24:1936-1945
47. McKenna N, Lanz R, O'Malley B (1999) Nuclear receptor coregulators: cellular and molecular biology. Endocrine Rev 20:321-344
48. Kobayashi Y, Kitamoto T, Masuhiro Y, Watanabe M, Kase T, Metzger D, Yanagisawa J, Kato S (2000) p300 mediates functional synergism between AF-1 and AF-2 of estrogen receptor alpha and beta by interacting directly with the N-terminal A/B domains. J Biol Chem 275:15645-15651
49. Pouponnot C, Jayaraman L, Massague J (1998) Physical and functional interaction of SMADs and p300/CBP. J Biol Chem 273:22865-22868
50. Buck M, Pfizenmaier K, Knabbe C (2004) Antiestrogens induce growth inhibition by sequential activation of p38 mitogen-activated protein kinase and transforming growth factor-beta pathways in human breast cancer cells. Mol Endocrinol 18:1643-1657
51. Eferl R, Wagner E (2003) AP-1: A double-edged sword in tumorigenesis. Nat Rev Cancer 3:859-868